Age-Related Decline of Autocrine Pituitary Adenylate Cyclase-Activating Polypeptide Impairs Angiogenic Capacity of Rat Cerebromicrovascular Endothelial Cells

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 6, 2015, Pages 665-674

  Banki, Eszter ^a,b   Sosnowska, Danuta ^a   Tucsek, Zsuzsanna ^a   Gautam, Tripti ^a   Toth, Peter ^a   Tarantini, Stefano ^a   Tamas, Andrea ^b   Helyes, Zsuzsanna ^c   Reglodi, Dora ^b   Sonntag, William E ^a   Csiszar, Anna ^a,b,d   Ungvari, Zoltan ^a,b,d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Institute for Translational Medicine   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Capillary density; Ischemia; Senescence; Vascular cognitive impairment; Vasculardementia

Indexed keywords

CASPASE 3; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

AGING; ANGIOGENESIS; ANIMAL; APOPTOSIS; BRAIN; CELL ADHESION; CELL CULTURE; CELL MOTION; DOWN REGULATION; ENDOTHELIUM CELL; FISCHER 344 RAT; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VASCULARIZATION;

AGING; ANIMALS; APOPTOSIS; BRAIN; CASPASE 3; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; NEOVASCULARIZATION, PHYSIOLOGIC; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84954108343     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu116     Document Type: Article

References (82)

1. Murugesan N, Demarest TG, Madri JA, Pachter JS. Brain regional angiogenic potential at the neurovascular unit during normal aging.Neurobiol Aging. 2012;33:1004.e1-1004.16.
2. Riddle DR, Sonntag WE, Lichtenwalner RJ. Microvascular plasticity in aging. Ageing Res Rev. 2003;2:149-168.
3. Sonntag WE, Deak F, Ashpole N, et al. Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front Aging Neurosci. 2013;5:27.
4. Shen Q, Wang Y, Kokovay E, et al.Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions.Cell Stem Cell. 2008;3:289-300.
5. Ungvari Z, Tucsek Z, Sosnowska D, et al.Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.J Gerontol A BiolSci Med Sci. 2013;68:877-891.
6. Miyata A, Arimura A, Dahl RR, et al.Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylatecyclase in pituitary cells. Biochem Biophys Res Commun.1989;164:567-574.
7. Arimura A, Somogyvári-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C.Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes.Endocrinology. 1991;129:2787-2789.
8. Vaudry D, Falluel-Morel A, Bourgault S, et al. Pituitary adenylatecyclaseactivating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev. 2009;61:283-357.
9. Reglodi D, Kiss P, Lubics A, Tamas A.Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des. 2011;17:962-972.
10. Reglodi D, Kiss P, Szabadfi K, et al. PACAP is an endogenous protective factor-insights from PACAP-deficient mice. J Mol Neurosci. 2012;48:482-492.
11. Sauvage M, Brabet P, Holsboer F, Bockaert J, Steckler T. Mild deficits in mice lacking pituitary adenylatecyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks. Brain Res Mol Brain Res. 2000;84:79-89.
12. Otto C, Kovalchuk Y, Wolfer DP, et al.Impairment of mossy fiber longterm potentiation and associative learning in pituitary adenylatecyclase activating polypeptide type I receptor-deficient mice. J Neurosci. 2001;21:5520-5527.
13. Matsuyama S, Matsumoto A, Hashimoto H, Shintani N, Baba A. Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylatecyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice. Neuroreport. 2003;14:2095-2098.
14. Ohtaki H, Satoh A, Nakamachi T, et al. Regulation of oxidative stress by pituitary adenylatecyclase-activating polypeptide (PACAP) mediated by PACAP receptor. J Mol Neurosci. 2010;42:397-403.
15. Szabadfi K, Kiss P, Reglodi D, et al. Differences between wild type and PACAP KO mice in retinal aging. J Mol Neurosci. 2013;51(Suppl 1):225-226.
16. Pirger Z, Nemeth J, Hiripi L, et al.PACAP has anti-apoptotic effect in the salivary gland of an invertebrate species, Helix pomatia. J Mol Neurosci. 2008;36:105-114.
17. Pirger Z, Naskar S, László Z, Kemenes G, Regl?di D, Kemenes I. Reversal of age related learning deficiency by the vertebrate pituitary adenylatecyclase activating polypeptide (PACAP) and insulin-like growth factor-1 (IGF-1) in a novel invertebrate model of aging: The pond snail (Lymnaea stagnalis). J Gerontol Biol Med Sci. In press.
18. Tripathy D, Sanchez A, Yin X, Martinez J, Grammas P.Age-related decrease in cerebrovascular-derived neuroprotective proteins: Effect of acetaminophen.Microvasc Res. 2012;84:278-285.
19. Baun M, Hay-Schmidt A, Edvinsson L, Olesen J, Jansen-Olesen I. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. Eur J Pharmacol. 2011;670:186-194.
20. Wilhelm I, Fazakas C, Tamas A, Toth G, Reglodi D, Krizbai IA. PACAP enhances barrier properties of cerebral microvessels. J MolNeurosci. In press. PMID: 24614973.
21. Lenti L, Zimmermann A, Kis D, et al. PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs. Brain Res. 2009;1283:50-57.
22. Warren JB, Donnelly LE, Cullen S, et al. Pituitary adenylatecyclase-activating polypeptide: A novel, long-lasting, endothelium-independent vasorelaxant. Eur J Pharmacol. 1991;197:131-134.
23. Rácz B, Gasz B, Borsiczky B, et al. Protective effects of pituitary adenylatecyclase activating polypeptide in endothelial cells against oxidative stressinduced apoptosis. Gen Comp Endocrinol. 2007;153:115-123.
24. Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev. 2007;59:185-205.
25. Ungvari Z, Podlutsky A, Sosnowska D, et al. Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: Role of increased DNA damage and decreased DNA repair capacity in microvascularradiosensitivity. J Gerontol A BiolSci Med Sci. 2013;68:1443-1457.
26. Toth P, Csiszar A, Tucsek Z, et al. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. Am J Physiol Heart Circ Physiol. 2013;305:H1698-H1708.
27. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159-1166.
28. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: Role of NF-{kappa}B inhibition. Am J Physiol. 2006;291:H1694-1699.
29. Csiszar A, Ahmad M, Smith KE, et al. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol. 2006;168:629-638.
30. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1. Mech Ageing Dev. 2009;130:518-527.
31. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010;299:H18-H24.
32. Ungvari Z, Bailey-Downs L, Gautam T, et al. Adaptive induction of NFE2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011;300:H1133-H1140.
33. Valcarcel-Ares MN, Gautam T, Warrington JP, et al. Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: Implications for microvascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:821-829.
34. Csiszar A, Sosnowska D, Tucsek Z, et al.Circulating factors induced by caloric restriction in the nonhuman primate Macacamulatta activate angiogenic processes in endothelial cells. J Gerontol A Biol Sci Med Sci. 2013;68:235-249.
35. Clapp C, Thebault S, Jeziorski MC, Martínez De La Escalera G. Peptide hormone regulation of angiogenesis. Physiol Rev. 2009;89:1177-1215.
36. Ungvari Z, Ridgway I, Philipp EE, et al. Extreme longevity Is associated with increased resistance to oxidative stress in Arctica islandica, the longest-living non-colonial animal. J Gerontol A Biol Sci Med Sci. 2011;66:741-750.
37. Bailey-Downs LC, Sosnowska D, Toth P, et al. Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: Implications for vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:553-564.
38. Csiszar A, Podlutsky A, Podlutskaya N, et al.Testing the oxidative stress hypothesis of aging in primate fibroblasts: Is there a correlation between species longevity and cellular ROS production? J Gerontol A Biol Sci Med Sci. 2012;67:841-852.
39. Ungvari Z, Sosnowska D, Podlutsky A, Koncz P, Sonntag WE, Csiszar A. Free radical production, antioxidant capacity, and oxidative stress response signatures in fibroblasts from lewis dwarf rats: Effects of life span-extending peripubertal GH treatment. J Gerontol A Biol Sci Med Sci. 2011.
40. Csiszar A, Pinto JT, Gautam T, et al. Resveratrol encapsulated in novel fusogenic liposomes activates Nrf2 and attenuates oxidative stress in cerebromicrovascular endothelial cells from aged rats. J Gerontol A Biol Sci Med Sci. 2014.
41. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: A novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:313-329.
42. Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesityinduced oxidative stress and inflammation in perivascular adipose tissue in mice: A paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci. 2013;68:780-792.
43. Ungvari Z, Orosz Z, Labinskyy N, et al. Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293:H37-H47.
44. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297:H1876-H1881.
45. Csiszar A, Sosnowska D, Wang M, Lakatta EG, Sonntag WE, Ungvari Z. Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: Reversal by resveratrol treatment. J Gerontol A Biol Sci Med Sci. 2012;67:811-820.
46. Marzetti E, Csiszar A, Dutta D, Balagopal G, Calvani R, Leeuwenburgh C. Role of mitochondrial dysfunction and altered autophagy in cardiovas-cular aging and disease: From mechanisms to therapeutics. Am J Physiol Heart Circ Physiol. 2013;305:H459-H476.
47. Toth P, Tarantini S, Tucsek Z, et al. Resveratrol treatment rescues neurovascular coupling in aged mice: Role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase. Am J Physiol Heart Circ Physiol. 2014;306:H299-H308.
48. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 2003;17:1183-1185.
49. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res. 2000;87:434-439.
50. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics. 2004;17:21-30.
51. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: Important role of nitric oxide. Circ Res. 2001;89:709-715.
52. Tucsek Z, Gautam T, Sonntag WE, et al. Aging exacerbates microvascular endothelial damage induced by circulating factors present in the serum of septic patients. J Gerontol A Biol Sci Med Sci. 2013;68:652-660.
53. Rácz B, Gallyas F Jr, Kiss P, et al. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways. Regul Pept. 2006;137:20-26.
54. Horvath G, Brubel R, Kovacs K, et al. Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. J Mol-Neurosci. 2011;43:67-75.
55. Mester L, Kovacs K, Racz B, et al.Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells. J Mol Neurosci. 2011;43:35-43.
56. Collado B, Gutiérrez-Cañas I, Rodríguez-Henche N, Prieto JC, Carmena MJ.Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul Pept. 2004;119:69-75.
57. Casibang M, Purdom S, Jakowlew S, et al. Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer. 2001;31:203-212.
58. Moody TW, Leyton J, Casibang M, Pisegna J, Jensen RT. PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regul Pept. 2002;109:135-140.
59. Gloddek J, Pagotto U, PaezPereda M, Arzt E, Stalla GK, Renner U. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol. 1999;160:483-490.
60. Benndorf RA, Schwedhelm E, Gnann A, et al. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: A potential link between oxidative stress and impaired angiogenesis. Circ Res. 2008;103:1037-1046.
61. Zlokovic BV.The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201.
62. Toth P, Tucsek Z, Sosnowska D, et al. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab. 2013;33:1732-1742.
63. Tucsek Z, Toth P, Sosnowska D, et al. Obesity in aging exacerbates blood brain barrier disruption, neuroinflammation and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J Gerontol Biol Med Sci. In press. PMID: 24269929.
64. Markhotina N, Liu GJ, Martin DK.Contractility of retinal pericytes grown on silicone elastomer substrates is through a protein kinase A-mediated intracellular pathway in response to vasoactive peptides. IET Nanobiotechnol. 2007;1:44-51.
65. Tatsuno I, Morio H, Tanaka T, et al. Astrocytes are one of the main target cells for pituitary adenylate cyclase-activating polypeptide in the central nervous system. Astrocytes are very heterogeneous regarding both basal movement of intracellular free calcium ([Ca2+]i) and the [Ca2+]i response to PACAP at a single cell level. Ann N Y Acad Sci. 1996;805:613-619.
66. Masmoudi-Kouki O, Douiri S, Hamdi Y, et al. Pituitary adenylate cyclaseactivating polypeptide protects astroglial cells against oxidative stressinduced apoptosis. J Neurochem. 2011;117:403-411.
67. Yang S, Yang J, Yang Z, et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: Potent regulators of microglia-mediated oxidative stress. J Pharmacol Exp Ther. 2006;319:595-603.
68. Köves K, Arimura A, Görcs TG, Somogyvári-Vigh A. Comparative distribution of immunoreactive pituitary adenylatecyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology. 1991;54:159-169.
69. Vigh S, Arimura A, Köves K, Somogyvári-Vigh A, Sitton J, Fermin CD. Immunohistochemical localization of the neuropeptide, pituitary adenylatecyclase activating polypeptide (PACAP), in human and primate hypothalamus. Peptides. 1991;12:313-318.
70. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR. Distribution, molecular characterization of pituitary adenylatecyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol. 1993;136:159-166.
71. Atlasz T, Babai N, Kiss P, et al. Pituitary adenylatecyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats. Gen Comp Endocrinol. 2007;153:108-114.
72. Rat D, Schmitt U, Tippmann F, et al. Neuropeptide pituitary adenylatecyclase-activating polypeptide (PACAP) slows down Alzheimer's diseaselike pathology in amyloid precursor protein-transgenic mice. FASEB J. 2011;25:3208-3218.
73. Brown D, Tamas A, Reglödi D, Tizabi Y. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: Implication for Parkinson's disease. J Mol Neurosci. 2013;50:600-607.
74. Dogrukol-Ak D, Kumar VB, Ryerse JS, et al. Isolation of peptide transport system-6 from brain endothelial cells: Therapeutic effects with antisense inhibition in Alzheimer and stroke models. J Cereb Blood Flow Metab. 2009;29:411-422.
75. Duncan MJ, Herron JM, Hill SA. Aging selectively suppresses vasoactive intestinal peptide messenger RNA expression in the suprachiasmatic nucleus of the Syrian hamster. Brain Res Mol Brain Res. 2001;87:196-203.
76. Krajnak K, Kashon ML, Rosewell KL, Wise PM. Aging alters the rhythmic expression of vasoactive intestinal polypeptide mRNA but not arginine vasopressin mRNA in the suprachiasmatic nuclei of female rats. J Neurosci. 1998;18:4767-4774.
77. Gozes I, Schächter P, Shani Y, Giladi E. Vasoactive intestinal peptide gene expression from embryos to aging rats. Neuroendocrinology. 1988;47:27-31.
78. Park L, Anrather J, Girouard H, Zhou P, Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab. 2007;27:1908-1918.
79. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12:723-738.
80. Lin AL, Zheng W, Halloran JJ, et al. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. J Cereb Blood Flow Metab. 2013;33:1412-1421.
81. Gorelick PB, Scuteri A, Black SE, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia.Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
82. Görgey A. Uber die festen, fluchtigen, fetten Saueren des Cocusnussoles. Sitzungsberichte der mathematisch-naturwissenschaftlichen Classe der k Akademie der Wissenschaften in Wien Vienna: Akademie der Wissenschaften in Wien; 1848:208?227.